Contact Us

     Bookmark and Share  
Donate
 
Skip Navigation Links
  living with myeloma
support
research
trials
webcasts
meetings
doctors & nurses
advocacy
fundraising
media
blogs
about IMF
 

Skip Navigation Links
IMF Home
------------
FUNdraisers
member events
veterans against myeloma
kids fight back
annual comedy celebration
founders' circle summit
kyle lifetime achievement award
Ways To Donate
make an individual donation
tributes and memorials
the hope society
matching gifts
fly a virtual kite
cell phones for a cure
buy imf merchandise
ebay/shop online for imf
combined federal campaign
Learn More
Making Miracles
major giving
planned giving
annual report
wall of miracles
volunteering
contact development
 


Don’t miss this exciting 
CME-certified session 
on
the latest in multiple myeloma 
"Critical Issues Need Answers: Providing
Best Options for Myeloma Treatment in 2013"




December 6, 2013

Registration & Lunch: 12:00 pm-12:30 pm

Live Program: 12:30 – 4:30 pm

Venue: Ernest N. Morial Convention Center, New Orleans

900 Convention Center Blvd, New Orleans, LA

Symposium Room(s): La Nouvelle Orleans Ballroom

 

Format and Topics:

The Symposium will have a unique program format that includes "Point & Counterpoint" presentations and interactive case discussions to promote audience participation.

Each point-counterpoint session will begin with an initial Clinical Question and why it is a clinical challenge followed by the presentation of 2 alternative views on the indicated issue.

Summaries of Key Relevant Data

Plus a follow up discussion open to all symposia faculty will be part of each session.

Symposium Topics Are:
  • Initiate Therapy for High-Risk Smoldering Myeloma—Yes or No?
  • Early Transplantation in Multiple Myeloma—Yes or No?
  • Melphalan as Part of Induction Therapy for the Elderly Patient—Yes or No?
  • Maintenance Therapy—Yes or No?
  • Early Integration of New Therapies in the Salvage Setting—Yes or No?
  Program Director:

Speaker 1: Brian G.M. Durie, MD
Institution: Cedars‐Sinai Outpatient Cancer Center, Los Angeles, California

Speaker 2: Shaji Kumar, MD
Institution: Mayo Clinic, Rochester, MN 

Speaker 3: Jesús F. San‐Miguel MD, PhD
Institution: University of Salamanca, Salamanca, Spain

Speaker 4: Philippe Moreau, MD
Institution: University Hospital Hôtel‐Dieu, Nantes, France

Speaker 5: Antonio Palumbo, MD
Institution: University of Turin, Turin, Italy

Speaker 6: S. Vincent Rajkumar, MD
Institution: Mayo Clinic College of Medicine, Rochester, Minnesota
Learning Objectives:
  • Incorporate new data and/or ongoing clinical trials into the management algorithm for patients with high-risk smoldering multiple myeloma
  • Choose optimal primary induction therapy for patients with multiple myeloma in both the transplantation-eligible and transplantation-ineligible settings
  • Plan optimal maintenance therapy approaches for patients with multiple myeloma
  • Choose optimal therapy for patients with relapsed/refractory multiple myeloma by applying current guideline recommendations and data on emerging therapeutic options
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

This activity is supported by educational grants from: AMGEN, Celgene Corporation, Millennium: The Takeda Oncology Company, ONYX Pharmaceuticals and The Binding Site.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Allison Hughes prior to the live event at ahughes@pimed.com.

Please choose your registration(s)

Quantity and Pricing
ASH 2013 Physician Education Program
Ernest N. Morial Convention Center,
New Orleans, LA
Friday, December 06, 2013 at 12:00 PM
 
Attendees: 1 No Charge

 

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421 | USA
Hotline: 800-452-2873
© International Myeloma Foundation. All Rights Reserved.
  living with myeloma | find support | research | clinical trials | webcasts | meetings & events | doctors & nurses | advocacy | about IMF | get involved | media | IMF Annual Report | IMF Federal Tax Form 990 | IMF Privacy Statement